jueves, 1 de noviembre de 2012

National Quality Measures Clearinghouse | Measures by Topic: Diabetic Retinopathy

National Quality Measures Clearinghouse | Measures by Topic: Diabetic Retinopathy


Measures by Topic

Diabetic Retinopathy (7)


1-7 of 7  
 
1.  
4.  
Diabetes mellitus: hospital admission rate for long-term complications. 2010 Sep. [NQMC Update Pending] NQMC:005597
Agency for Healthcare Research and Quality - Federal Government Agency [U.S.]. View all measures by the developer(s)
5.  
Eye care: percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy AND the presence or absence of macular edema during one or more office visits within 12 months. 2010 Sep. NQMC:002935
American Academy of Ophthalmology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s)
6.  
Eye care: percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the on-going care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months. 2010 Sep. NQMC:002936
American Academy of Ophthalmology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s)
7.  
Diabetes mellitus: the percentage of patients with diabetes who have a record of retinal screening in the previous 15 months. 2009 Mar. [NQMC Update Pending] NQMC:005070
British Medical Association - Medical Specialty Society; National Health Service (NHS) Confederation - National Government Agency [Non-U.S.]. View all measures by the developer(s)

No hay comentarios: